Zydus Lifesciences Share price target & analyst calls
₹1,117.3+3.40 (+0.31%)
As of 21 Oct 2026
Avg 1-year target
6 of 7 long-term calls BUY₹1,310.3317.3% above today's price
Zydus Lifesciences' average 1-year share price target is ₹1,310.33, the average of 6 advisors' latest targets. Targets range from ₹1,040 to ₹1,457.
Latest: Bernstein ₹1,457 · 18 Sept 2026
7
6 BUY · 1 SELL, all horizons
6
with an active 1Y target
33%
17 of 52 closed calls hit
59
all horizons, open and closed
Watch ZYDUSLIFE for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
Zydus Lifesciences target price by brokerage
Each advisor's latest 1-year target · 6 advisors · tap a row for the call
- BBernsteinHigh18 Sept 2026 · via CNBC Awaaz.₹1,457+30.4%
- JIJefferies India12 Aug 2026 · via CNBC Awaaz.₹1,370+22.6%
- CCitigroupLow12 Aug 2026 · SELL call · via CNBC Awaaz.₹1,040-6.9%
- CCLSA12 Aug 2026 · via CNBC Awaaz.₹1,310+17.2%
- NWNuvama Wealth12 Aug 2026 · via ET Now (Live)₹1,400+25.3%
- MMacquarie11 Aug 2026 · via NDTV Profit₹1,285+15.0%
All tips (59)
BbyBernstein+30.4% to target
1 Year* · 11 mo left · 18 Sept 2026 · entry ₹1,150.7 · via CNBC Awaaz.P&L -2.9%
JIbyJefferies India+22.6% to target
1 Year* · 10 mo left · 12 Aug 2026 · entry ₹1,190 · via CNBC Awaaz.P&L -6.1%
CbyCitigroup+6.9% to target
1 Year* · 10 mo left · 12 Aug 2026 · entry ₹1,190 · via CNBC Awaaz.P&L +6.1%
NWbyNuvama Wealth+25.3% to target
1 Year* · 10 mo left · 12 Aug 2026 · entry ₹1,190 · via ET Now (Live)P&L -6.1%
JIbyJefferies India+15.0% to target
1 Year* · 10 mo left · 11 Aug 2026 · entry ₹1,122.6 · via Zee Business (Live)P&L -0.5%
MbyMacquarie+15.0% to target
1 Year · 10 mo left · 11 Aug 2026 · entry ₹1,119 · via NDTV ProfitP&L -0.2%
IIbyInvestec IndiaTarget hit
1 Year* · 12 Aug 2026 · entry ₹1,190 · via NDTV Profit (Live)exit ₹1,090
DCbyDeven Choksey, DRChokseyTarget hit
1 Year* · 7 Nov 2025 · entry ₹936.7 · via Institutional / Brokerage Researchexit ₹1,121
GFbyGeojit Financial ServicesTarget hit
1 Year* · 3 Sept 2025 · entry ₹1,008.2 · via Institutional / Brokerage Researchexit ₹1,121
DCbyDeven Choksey, DRChokseyTarget hit
1 Year* · 25 Aug 2025 · entry ₹1,023.15 · via Institutional / Brokerage Researchexit ₹1,183
DCbyDeven Choksey, DRChokseyTarget hit
1 Year* · 25 Jul 2025 · entry ₹971.25 · via Institutional / Brokerage Researchexit ₹1,069
GFbyGeojit Financial ServicesTarget hit
1 Year* · 16 Apr 2025 · entry ₹822.1 · via Institutional / Brokerage Researchexit ₹975
SRbySharekhan ResearchTarget hit
1 Year* · 20 Mar 2024 · entry ₹971.4 · via Institutional / Brokerage Researchexit ₹1,100
SRbySharekhan ResearchExpired
1 Year* · 18 Nov 2024 · entry ₹944.7 · via Institutional / Brokerage Researchexit ₹928.4
SRbySharekhan ResearchExpired
1 Year* · 3 Oct 2024 · entry ₹1,069.05 · via Institutional / Brokerage Researchexit ₹988.3
AKbyAshish Kyal, Waves Strategy AdvisorsTarget hit
1–2 Weeks* · 24 Sept 2026 · entry ₹1,175 · via ET Now (Live)exit ₹1,220
KPbyKunal Parar, Choice BrokingTarget hit
1–2 Weeks* · 25 Aug 2026 · entry ₹1,127.4 · via ET Nowexit ₹1,150
SMbySomil Mehta, SharekhanTarget hit
1–2 Weeks* · 7 Aug 2026 · entry ₹1,114.9 · via CNBC Awaaz.exit ₹1,190
ICbyIDBI CapitalTarget hit
1–2 Weeks* · 3 Jul 2026 · entry ₹1,122 · via IDBI Capital Research Calls Telegramexit ₹1,164
SRbySiddharth Rai MangalaStop-loss hit
1–2 Weeks* · 15 Oct 2026 · entry ₹1,143.5 · via Zee Business (Live)exit ₹1,135
KJbyKavita Jain, Arihant Capital MarketsStop-loss hit
1–2 Weeks* · 6 Oct 2026 · entry ₹1,162.5 · via CNBC Awaaz.exit ₹1,145
RJbyRuchit Jain, Motilal OswalStop-loss hit
1–2 Weeks* · 29 Sept 2026 · entry ₹1,217.6 · via NDTV Profitexit ₹1,180
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–2 Weeks* · 29 Sept 2026 · entry ₹1,217.6 · via ET Now (Live)exit ₹1,175
AJbyAnsh Jogendra BhilwarStop-loss hit
1–2 Weeks · 29 Sept 2026 · entry ₹1,217.6 · via Zee Business (Live)exit ₹1,198
KPbyKunal Parar, Choice BrokingStop-loss hit
1–2 Weeks* · 25 Sept 2026 · entry ₹1,198.3 · via ET Now (Live)exit ₹1,150
RSbyRajesh SatputeStop-loss hit
1–2 Weeks* · 23 Sept 2026 · entry ₹1,173 · via CNBC Awaaz.exit ₹1,158
MJbyManas JaiswalStop-loss hit
1–2 Weeks* · 7 Sept 2026 · entry ₹1,161.7 · via CNBC Awaaz.exit ₹1,124
AMbyAjit Mishra, ReligareStop-loss hit
1–2 Weeks* · 12 Aug 2026 · entry ₹1,161.6 · via NDTV Profit (Live)exit ₹1,130
SMbySomil Mehta, SharekhanStop-loss hit
1–2 Weeks* · 29 Jul 2026 · entry ₹1,124.4 · via CNBC Awaaz.exit ₹1,095
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 20 Jul 2026 · entry ₹1,160 · via IDBI Capital Research Calls Telegramexit ₹1,138
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 15 Jul 2026 · entry ₹1,158 · via IDBI Capital Research Calls Telegramexit ₹1,136
KJbyKavita Jain, Arihant Capital MarketsStop-loss hit
1–2 Weeks* · 23 Jun 2026 · entry ₹1,117 · via CNBC Awaaz.exit ₹1,100
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–2 Weeks* · 10 Jun 2026 · entry ₹1,115.4 · via CNBC Awaaz.exit ₹1,075
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks* · 10 Jun 2026 · entry ₹1,109.2 · via CNBC Awaaz.exit ₹1,090
ABbyAkshay Bhagwat, JM FinancialStop-loss hit
1–2 Weeks* · 8 Jun 2026 · entry ₹1,087.6 · via ET Nowexit ₹1,060
AKbyAshish Kyal, Waves Strategy AdvisorsStop-loss hit
1–2 Weeks* · 4 Jun 2026 · entry ₹1,085.1 · via ET Nowexit ₹1,060
AMbyAjit Mishra, ReligareExpired
1–2 Weeks · 29 Sept 2026 · entry ₹1,217.6 · via NDTV Profit (Live)exit ₹1,132.5
AJbyAnsh Jogendra BhilwarExpired
1–2 Weeks* · 27 Aug 2026 · entry ₹1,160 · via Zee Business (Live)exit ₹1,127.4
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Full call history, all horizons: page 2 of 2
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,346+8.1% · 19 calls
- CIPLACipla Ltd.₹1,524+16.0% · 17 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+27.5% · 15 calls
- BIOCONBiocon Ltd₹485+44.8% · 12 calls
- LUPINLupin Limited₹2,576+31.2% · 12 calls
- ZYDUSLIFE· this stockZydus Lifesciences Limited₹1,310+17.3% · 7 calls

